A 38-year-old man presents to the office to evaluate a newly discovered mass in his neck. … — USMLE Step 2 CK

A $38$ -year-old man presents to the office to evaluate a newly discovered mass in his neck. He first noticed it while shaving two weeks ago. The patient reports no dysphagia, hoarseness, palpitations, headaches, or diaphoresis. He was adopted as a child and his family medical history is unknown. He takes no medications. Vital signs include a blood pressure of $152/94$ mm Hg and a heart rate of $88$ /min. Physical examination reveals a $2.7$ -cm, firm, non-tender nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is appreciated. Laboratory testing shows a serum thyroid-stimulating hormone level of $1.8$ $\mu\text{U}/\text{mL}$ (normal: $0.4$ - $4.0$ $\mu\text{U}/\text{mL}$ ). An ultrasound of the neck confirms a solid, hypoechoic right thyroid nodule with irregular margins. A subsequent fine-needle aspiration biopsy of the nodule yields cytology consistent with medullary thyroid carcinoma. Which of the following is the most appropriate next step in the management of this patient?

Assessment of plasma fractionated metanephrinesCevap
B
Evaluation of serum thyroglobulin concentration
C
Scheduling for immediate total thyroidectomy with lymph node dissection
D
Prescription of high-dose levothyroxine to suppress TSH
E
Referral for I-131 targeted ablation

Cevap

The correct answer is the assessment of plasma fractionated metanephrines.

The most appropriate next step in management is the assessment of plasma fractionated metanephrines. This patient has a biopsy-confirmed medullary thyroid carcinoma (MTC). MTC is a neuroendocrine tumor arising from the parafollicular C cells of the thyroid gland. Up to

25\%

of MTC cases occur as part of a familial syndrome, specifically Multiple Endocrine Neoplasia (MEN) type 2A or 2B. Both of these syndromes are characterized by a high risk of developing a pheochromocytoma (a catecholamine-secreting tumor of the adrenal medulla). Because this patient is adopted, his family history is unknown, making a hereditary syndrome entirely possible. If a patient with an undiagnosed pheochromocytoma undergoes induction of anesthesia and surgical manipulation, the resulting physiologic stress can precipitate a massive release of catecholamines. This leads to a life-threatening intraoperative hypertensive crisis, arrhythmias, and potentially death. Therefore, it is absolutely mandatory to screen all patients with MTC for a coexisting pheochromocytoma using biochemical tests (such as plasma fractionated free metanephrines or 24-hour urine metanephrines and catecholamines) before proceeding with a thyroidectomy. If a pheochromocytoma is diagnosed, it must be surgically resected first, following appropriate preoperative alpha- and beta-adrenergic blockade.

Adım Adım Çözüm

Analyze the fine-needle aspiration (FNA) biopsy result.

The patient is diagnosed with medullary thyroid carcinoma (MTC).

Establishing the specific histologic subtype of the thyroid nodule dictates the entire subsequent evaluation and treatment pathway.

Recall the systemic associations and genetic implications of MTC.

MTC is strongly associated with Multiple Endocrine Neoplasia (MEN) types 2A and 2B, both of which feature pheochromocytomas.

Even in seemingly sporadic cases (especially in a patient with an unknown family history), a RET proto-oncogene mutation and an occult pheochromocytoma may be present.

Determine the safety prerequisites for surgical intervention.

A pheochromocytoma must be definitively ruled out before inducing anesthesia for a thyroidectomy.

Surgical stress and anesthetic agents can trigger a massive catecholamine release from an undiagnosed pheochromocytoma, leading to a catastrophic intraoperative hypertensive crisis.

Select the appropriate diagnostic test to screen for the critical comorbidity.

Measure plasma fractionated metanephrines (or 24-hour urine metanephrines and catecholamines).

This is the most sensitive initial biochemical test to evaluate for a catecholamine-secreting adrenal tumor.

Anahtar Kavram

Before undergoing thyroidectomy, all patients newly diagnosed with medullary thyroid carcinoma must be biochemically screened for a coexisting pheochromocytoma (e.g., using plasma fractionated metanephrines) to prevent a life-threatening intraoperative hypertensive crisis.

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru